|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.44 USD | +0.29% |
|
+3.18% | -25.62% |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 1.11B 967M 891M 835M 1.56B 107B 1.59B 10.63B 4.11B 51.41B 4.18B 4.09B 179B | P/E Ratio 2026 * |
12.9x | P/E Ratio 2027 * | 9.21x |
|---|---|---|---|---|---|
| Enterprise Value | 1.86B 1.62B 1.49B 1.4B 2.61B 179B 2.67B 17.79B 6.89B 86.06B 7B 6.85B 299B | EV / Sales 2026 * |
2.13x | EV / Sales 2027 * | 1.63x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | +0.52% | ||
| 1 week | +3.18% | ||
| Current month | +2.47% | ||
| 1 month | -3.50% | ||
| 3 months | -1.60% | ||
| 6 months | -29.18% | ||
| Current year | -25.62% |
| 1 week | 33.11 |  | 35.52 |
| 1 month | 30.13 | | 36.47 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.08 | | 50.79 |
| 3 years | 20.83 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-08 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 05-18 | Sell | Director | -20 | 0.0001% | ||
| 05-15 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | +3.18% | +16.35% | +55.28% | 1.11B | |
| -0.38% | +2.30% | +42.53% | +159.91% | 1,035B | |
| -0.05% | +2.71% | +52.60% | +49.51% | 574B | |
| +0.19% | -0.42% | +17.59% | +64.29% | 397B | |
| +0.63% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.32% | -2.27% | +22.79% | +14.49% | 281B | |
| +0.82% | +3.85% | +24.93% | +34.87% | 278B | |
| +1.25% | +4.98% | -45.00% | -47.80% | 193B | |
| -0.17% | +0.93% | +18.68% | +62.33% | 191B | |
| -0.82% | -3.44% | +11.31% | +60.18% | 156B | |
| Average | +0.20% | +2.02% | +18.30% | +46.90% | 343.11B | |
| Weighted average by Cap. | +0.05% | +2.39% | +28.59% | +73.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 875M 759M 700M 656M 1.22B 83.74B 1.25B 8.35B 3.23B 40.37B 3.28B 3.21B 140B | 886M 769M 709M 664M 1.24B 84.82B 1.27B 8.45B 3.27B 40.89B 3.33B 3.25B 142B |
| Net income | 108M 93.92M 86.57M 81.12M 152M 10.36B 155M 1.03B 400M 5B 406M 398M 17.37B | 158M 137M 127M 119M 222M 15.16B 226M 1.51B 585M 7.31B 594M 581M 25.4B |
| Net Debt | 751M 652M 601M 563M 1.05B 71.89B 1.07B 7.16B 2.77B 34.66B 2.82B 2.76B 120B | 328M 284M 262M 246M 459M 31.38B 468M 3.13B 1.21B 15.12B 1.23B 1.2B 52.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 34.44 $ | +0.29% | 20,391 |
| 11/06/26 | 34.34 $ | -1.32% | 461,388 |
| 10/06/26 | 34.80 $ | +1.16% | 374,980 |
| 09/06/26 | 34.40 $ | +3.40% | 258,278 |
| 08/06/26 | 33.27 $ | -0.33% | 422,374 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Select your edition
All financial news and data tailored to specific country editions
